These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23817325)

  • 41. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experience with an anti-TNFalpha in rheumatology].
    Goupille P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 2):4S10-4S12. PubMed ID: 16335347
    [No Abstract]   [Full Text] [Related]  

  • 43. Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo- and polyarticular juvenile idiopathic arthritis (JIA).
    Kaminiarczyk-Pyzalka D; Adamczak K; Mikos H; Klimecka I; Moczko J; Niedziela M
    Clin Lab; 2014; 60(9):1481-90. PubMed ID: 25291944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New indications for treatment of chronic inflammation by TNF-alpha blockade.
    Reimold AM
    Am J Med Sci; 2003 Feb; 325(2):75-92. PubMed ID: 12589232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.
    Luo M; Guo JY; Cao WK
    World J Gastroenterol; 2015 Nov; 21(41):11815-24. PubMed ID: 26557005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone mineral density improvement in spondyloarthropathy after treatment with etanercept.
    Marzo-Ortega H; McGonagle D; Haugeberg G; Green MJ; Stewart SP; Emery P
    Ann Rheum Dis; 2003 Oct; 62(10):1020-1. PubMed ID: 12972490
    [No Abstract]   [Full Text] [Related]  

  • 47. Rapid improvement in severe long COVID following perispinal etanercept.
    Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
    Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience with intravenous immunoglobulin and tnf-a inhibitor therapies for recurrent pregnancy loss.
    Sills ES; Walsh DJ; Shkrobot LV; Palermo GD; Walsh AP
    Ulster Med J; 2009 Jan; 78(1):57-8. PubMed ID: 19252735
    [No Abstract]   [Full Text] [Related]  

  • 49. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of TNF inhibitor on innate inflammatory and Th17 cytokines in stimulated whole blood from rheumatoid arthritis patients.
    Zivojinovic S; Pejnovic N; Sefik-Bukilica M; Kovacevic L; Soldatovic I; Bugarski D; Mojsilovic S; Damjanov N
    Inflammopharmacology; 2012 Dec; 20(6):323-30. PubMed ID: 22733231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
    Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
    PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated circulating TGFβ1 during acute liver failure activates TGFβR2 on cortical neurons and exacerbates neuroinflammation and hepatic encephalopathy in mice.
    McMillin M; Grant S; Frampton G; Petrescu AD; Williams E; Jefferson B; Thomas A; Brahmaroutu A; DeMorrow S
    J Neuroinflammation; 2019 Apr; 16(1):69. PubMed ID: 30940161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.
    Watanabe S; Aizawa-Yashiro T; Tsuruga K; Kinjo M; Ito E; Tanaka H
    Rheumatol Int; 2013 Dec; 33(12):3105-8. PubMed ID: 23266507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
    Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
    CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
    Farnsworth NN; George SJ; Hsu S
    Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapeutic management of plaque psoriasis: the interest of anti-TNFalpha].
    Ortonne JP
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 2):4S6-4S9. PubMed ID: 16335346
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of pyoderma gangrenosum with etanercept.
    McGowan JW; Johnson CA; Lynn A
    J Drugs Dermatol; 2004; 3(4):441-4. PubMed ID: 15303791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.
    Bémeur C; Vaquero J; Desjardins P; Butterworth RF
    Metab Brain Dis; 2010 Jun; 25(2):241-9. PubMed ID: 20431929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis.
    Menon KV; Stadheim L; Kamath PS; Wiesner RH; Gores GJ; Peine CJ; Shah V
    Am J Gastroenterol; 2004 Feb; 99(2):255-60. PubMed ID: 15046213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.